Last reviewed · How we verify

NCT04893902

Digital VS. Conventional Ear Impression

Status unknown NA Last updated 20 May 2021
What this trial tests

NA trial testing medit intra oral scanner in Patient Loss His Ear and Need Auricular Prosthesis in 8 participants. Status unknown.

Timeline
15 May 2021
Primary endpoint
16 May 2021
17 May 2021

Quick facts

Lead sponsorMohamed Mahmoud Dohiem
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment8
Start date15 May 2021
Primary completion16 May 2021
Estimated completion17 May 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mohamed Mahmoud Dohiem

Who can join

Eligibility, any sex, with Patient Loss His Ear and Need Auricular Prosthesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

What is known: Ear impressions are made in conventional manner by impression materials which may affect the accuracy of the obtained data and consume time and effort . What this study adds: Predesigned ear markers facilitate ear scanning using an intraoral scanner that decreases the probability of in-accuracies using the conventional manner with less time and effort

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Accuracy of digital auricular impression using intraoral scanner versus conventional impression technique for ear rehabilitation: A controlled clinical trial.
    Dohiem MM, Emam NS, Abdallah MF, Abdelaziz MS. · · 2022 · cited 10× · PMID 36117136 · DOI 10.1016/j.bjps.2022.08.002

Verify or expand the search:

Other Mohamed Mahmoud Dohiem trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04893902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing